Viewing Study NCT06832618


Ignite Creation Date: 2025-12-25 @ 4:42 AM
Ignite Modification Date: 2026-03-05 @ 6:57 PM
Study NCT ID: NCT06832618
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2025-02-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis
Sponsor: Incyte Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module